Aug 5, 2024, 16:33
Diogo Martins Branco: MDICT’24 recommendations are out
Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek, the Netherlands Cancer Institute, shared a post by
, on LinkedIn:“It was wonderful to participate as a rare surgical oncologist in this ambitious and engaged group of experts in early anti cancer drug trials, to set a standard for designing trials for new anticancer drugs before curative intend surgery.
Well done alll and especially Lesley Seymour for being the driving force behind this.”
Quoting
“MDICT’24 recommendations are out
Testing new anticancer drugs before curative locoregional therapies
4 key concepts:
- patient engagement
- risk–benefit ratio and clinical/ethical equipoise
- randomization to reduce bias and allow robust conclusions
- appropriate endpoints
Open access at ESMO Open.”
Source: Winan van Houdt/LinkedIn and /LinkedIn
Aug 11, 2024, 04:55
Aug 11, 2024, 04:37
Aug 11, 2024, 02:26
Aug 10, 2024, 19:12